Dermata Therapeutics (DRMA) vs Onconetix (ONCO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Dermata Therapeutics is the larger company by market cap ($2.5 million vs $2.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DRMA | ONCO |
|---|---|---|
| Share price | $0.5095 | $2.89 |
| Market cap | $2.51M | $2.37M |
| 1-day change | -4.23% | -8.54% |
| P/E ratio (TTM) | — | 0.00 |
| EPS (TTM) | $-3.28 | $4,509.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $815.37K |
| Revenue growth (YoY) | — | -67.70% |
| Net income (latest FY) | $-7.56M | $-14.03M |
| Gross margin | — | 77.62% |
| Operating margin | — | -2190.03% |
| Net margin | — | -1720.98% |
| 52-week high | $4.66 | $1,610.00 |
| 52-week low | $0.50 | $2.76 |
| Distance from 52-week high | -89.07% | -99.82% |
| Analyst consensus | none | — |
| Avg. price target upside | +685.08% | — |
| Average volume | 2.78M | 412.90K |
| Shares outstanding | 4.93M | 820.61K |
| Employees | 9 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Dermata Therapeutics
DRMA stock →Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 9 employees
About Onconetix
ONCO stock →Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
DRMA vs ONCO FAQ
Which is bigger, Dermata Therapeutics or Onconetix?
Dermata Therapeutics (DRMA) is larger, with a market capitalization of $2.51M compared with $2.37M for Onconetix (ONCO).
Are Dermata Therapeutics and Onconetix in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.